Sarpogrelate clinical trials
Also written Anplag and MCI-9042.
How each study uses sarpogrelate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
18 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 8
Daewoong Pharmaceutical Co. LTD. (4) · Yuhan Corporation (2) · Seoul National University Bundang Hospital (2) · Mitsubishi Tanabe Pharma Corporation (2) · Alvogen Korea (2) · University of Karachi (1) · Ajou University School of Medicine (1) · Samsung Medical Center (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses sarpogrelate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 18
- Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive DiseaseCompletedPhase 4Yuhan CorporationNCT06046196Written as Sarpogrelate SR
- Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting ConditionCompletedPhase 1University of KarachiNCT04941196Written as Anplag (Ticagrelor 90 mg)
- Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)CompletedPhase 4Yuhan CorporationNCT01869881Written as Anplag(Sarpogrelate)
- Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting ConditionsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT03947489Written as Sarpogrelate HCL 300mg
- Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed ConditionsStatus unknownPhase 1Daewoong Pharmaceutical Co. LTD.NCT03947528Written as Sarpogrelate HCL 300mg
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting ConditionsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT03573622Written as Anpl-one SR Tab. 300mg
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding ConditionsCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT03574285Written as Anpl-one SR Tab. 300mg
- The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary SpasmStatus unknownPhase 4Samsung Medical CenterNCT01674686Written as Sarpogrelate
- SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) StudyStatus unknownPhase 4Seoul National University HospitalNCT02959606Written as Sarpogrelate SR 300mg
- Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery DiseaseCompletedPhase 4Seoul National University Bundang HospitalNCT02607436Written as Sarpogrelate
- Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology StudyCompletedPhase 3Mitsubishi Tanabe Pharma CorporationNCT00147303Written as MCI-9042
- Sarpogrelate Drug InteractionCompletedPhase 1Ajou University School of MedicineNCT02097511Written as Sarpogrelate
- Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' StudyCompletedPhase 3Seoul National University Bundang HospitalNCT02294643Written as Sarpogrelate
- Impact of Sarpogrelate in the Function of Endothelial Progenitor CellsStatus unknownNot applicableAichi Gakuin UniversityNCT01548274Written as Sarpogrelate
- Pharmacokinetic / Pharmacodynamic (PK/PD) Study of Multiple Doses of DP-R202 in Healthy VolunteersCompletedPhase 1Alvogen KoreaNCT01429688Written as Anplag
- Safety and Pharmacokinetic Characteristics of DP-R202 in Healthy Male VolunteersCompletedPhase 1Alvogen KoreaNCT01421563Written as Anplag
- The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney DiseaseStatus unknownPhase 4Seoul National University Boramae HospitalNCT01165567Written as sarpogrelate
- Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)CompletedPhase 3Mitsubishi Tanabe Pharma CorporationNCT00129805Written as MCI-9042
Given beside what is tested · 1 — sarpogrelate is usual care or a partner of the new treatment
Codes
What other systems call sarpogrelate · ClinicalTrials.gg INT003515
- MeSH (NLM) C064294sarpogrelateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 19P708E787SARPOGRELATEConfirmed FDA, NLM, Wikidata
- Wikidata Q44931sarpogrelateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73158SarpogrelateOne source FDA
- DrugBank DB12163One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064294 | sarpogrelate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 19P708E787 | SARPOGRELATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q44931 | sarpogrelate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73158 | Sarpogrelate | One source FDA |
| DrugBank | DB12163 | — | One source Wikidata |
Also registered as sarpogrelate hydrochloride (UNII FQN8N8QP1B).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.